IPOTARX
Should You Buy the Tarsier Pharma IPO? Here's the Setup
Tarsier Pharma Ltd. (NYSE: TARX) is expected to list on 2026-07-09, with 5,000,000 shares priced at $8.00 to $10.00 each. The company is a late-stage ophthalmic biotech with no product revenue yet, so the setup hinges on clinical progress rather than current sales.
Jul 2, 20265 MIN